SPONSOR
National Heart, Lung, and Blood Institute (NHLBI)
Total Trials
10
Recruiting
10
Phases
Phase 1, Phase 2
Conditions studied: Cardiovascular DiseaseHealthy VolunteersNormal and Abnormal Cardiovascular PhysiologyLymphangioleiomyomatosisHealthy SubjectsSickle CellPKLR VariantsAdenosine Triphosphate ActivitiesLung TransplantEnd Stage Lung Disease
National Heart, Lung, and Blood Institute (NHLBI) is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Cardiovascular Disease, Healthy Volunteers, Normal and Abnormal Cardiovascular Physiology, Lymphangioleiomyomatosis.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Heart, Lung, and Blood Institute (NHLBI)
How many clinical trials has National Heart, Lung, and Blood Institute (NHLBI) sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by National Heart, Lung, and Blood Institute (NHLBI), of which 10 are actively recruiting participants. These trials cover conditions including Cardiovascular Disease, Healthy Volunteers, Normal and Abnormal Cardiovascular Physiology. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Heart, Lung, and Blood Institute (NHLBI) research focus on?
National Heart, Lung, and Blood Institute (NHLBI) clinical trials span Cardiovascular Disease, Healthy Volunteers, Normal and Abnormal Cardiovascular Physiology, Lymphangioleiomyomatosis, Healthy Subjects, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Heart, Lung, and Blood Institute (NHLBI) clinical trial?
To participate in a National Heart, Lung, and Blood Institute (NHLBI) trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Heart, Lung, and Blood Institute (NHLBI) trials with current recruitment status updated daily.
Clinical Trials by National Heart, Lung, and Blood Institute (NHLBI)
NCT04927429
Recruiting
Technical Development of Cardiovascular Magnetic Resonance Imaging
Cardiovascular Disease
NCT00442195
Recruiting
Collection and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers
Healthy Volunteers
NCT03581318
Recruiting
Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
Normal and Abnormal Cardiovascular Physiology
NCT01799538 Phase 1, Phase 2
Recruiting
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Lymphangioleiomyomatosis
NCT02417714
Recruiting
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Healthy Subjects
NCT03685721
Recruiting
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
Sickle Cell
NCT07516379
Recruiting
GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation
Lung Transplant
NCT02543996
Recruiting
Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)
Undiagnosed Diseases
NCT01927783
Recruiting
Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
Cardiovascular Disease
NCT07137429
Recruiting
Platelet Volunteers, Longitudinal and Multi-omic Study
Thrombosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology